Clofarabine in refractory Langerhans cell histiocytosis
- 11 July 2008
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 51 (5), 703-706
- https://doi.org/10.1002/pbc.21668
Abstract
Patients with multi‐system Langerhans cell histiocytosis (LCH) who progress on frontline therapy have a dismal outcome. Responses to cladribine have been reported in relapsed LCH, but there are no well defined salvage regimens for LCH is refractory to therapy. The next generation deoxyadenosine analog, clofarabine, has demonstrated activity in patients with leukemia that is refractory to salvage regimens, including other nucleotide congeners; however, no experience exist on the use of clofarabine in LCH. In this report we describe significant single agent activity of clofarabine in disseminated LCH refractory to salvage regimens, including cladribine. Pediatr Blood Cancer 2008;51:703–706.Keywords
This publication has 20 references indexed in Scilit:
- Langerhans cell histiocytosis: update for the pediatricianCurrent Opinion in Pediatrics, 2008
- Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2‐chlorodeoxyadenosinePediatric Blood & Cancer, 2007
- Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunctionEuropean Journal of Cancer, 2005
- Efficacy of continuous infusion 2‐CDA (cladribine) in pediatric patients with Langerhans cell histiocytosisPediatric Blood & Cancer, 2004
- Langerhans cell histiocytosis: A pathologic combination of oncogenesis and immune dysregulationPediatric Blood & Cancer, 2004
- Clofarabine, a novel nucleoside analog, is active in pediatric patients with advanced leukemiaBlood, 2004
- Oral methotrexate and alternate‐day prednisone for low‐risk langerhans cell histiocytosisMedical and Pediatric Oncology, 1995
- Treatment strategy for disseminated langerhans cell histiocytosisMedical and Pediatric Oncology, 1994
- Cytosine‐arabinoside, vincristine, and prednisolone in the treatment of children with disseminated langerhans cell histiocytosis with organ dysfunction: Experience at a single institutionMedical and Pediatric Oncology, 1993
- Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.JCI Insight, 1990